How is Modern Technology Enhancing Histology-Based Therapies?
Advancements in technology are significantly enhancing the development of histology-based therapies:
Immunohistochemistry (IHC): IHC techniques help in identifying specific proteins in tissues, aiding in the diagnosis and selection of targeted therapies. Next-Generation Sequencing (NGS): NGS allows for comprehensive genomic profiling of tissues, identifying potential therapeutic targets at the molecular level. CRISPR-Cas9: This gene-editing technology enables precise modifications of the genome, offering potential for correcting genetic defects and developing personalized therapies. 3D Tissue Culture: 3D culture systems better mimic the in vivo environment, providing more accurate models for testing therapeutic efficacy and safety.
